New hope for kids with severe alopecia? EMA reviews novel treatment
Legacy Healthcare announced today that the European Medicines Agency (EMA) has validated the company’s Marketing Authorisation Application (MAA) for Coacillium for the treatment of moderate and severe alopecia areata in children and adolescents. Alopecia areata is an autoimmune disorder that causes hair loss. It affects about 2% of the population, and children and adolescents are…